Arca
Skip to content
Tools
Tools

BC Thrombin Reagent

Test, Thrombin Time. 510(k) K970645, from Behring Diagnostics, Inc. (San Jose, CA). Product code GJA, class 2.

As of Nov 20, 2026, K970645 is an FDA 510(k) held by Behring Diagnostics, Inc., substantially equivalent on May 19, 1997 after 88 days, with 2 recalls tied to it in FDA's recall database.

  • Review time: 88 days
  • Recalls: 2
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The BC Thrombin Reagent is used for the determination of the thrombin time in human plasma. The determination of thrombin time is important in: • The monitoring of heparin therapy. • The monitoring of fibrinolysis therapy. • The screening of disorders of fibrin formation. - The differentiating between a heparin-induced prolongation of the thrombin time and fibrin formation disorders.

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K970645, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
Oct 17, 2017Z-0827-2018The BC Thrombin Reagent kit lot 46751 (contains Thrombin Reagent lot 517468) and kit lot 47184 (contains Thrombin Reagent lot 517469) produce unexpected prolonged Thrombin Time (TT) results for expected normal samples,…Terminated
Jul 21, 2004Z-0007-05The product does not demonstrate the expected prolonged thrombin times for specimens obtained from patients recieving heparinTerminated

Record

Type
Traditional
Received
Feb 20, 1997
Review panel
Hematology
Regulation
21 CFR 864.7875

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.